Litcius/Paper detail

FDA approves first TCR-engineered T cell therapy, for rare soft-tissue cancer

Asher Mullard

2024Nature Reviews Drug Discovery16 citationsDOI

Topics & Concepts

T-cell receptorCancer researchCancer therapySoft tissueMedicineCancerOncologyPathologyInternal medicineT cellImmunologyImmune systemCAR-T cell therapy researchCutaneous lymphoproliferative disorders researchSarcoma Diagnosis and Treatment
FDA approves first TCR-engineered T cell therapy, for rare soft-tissue cancer | Litcius